Biomedical Engineering – From Theory to Applications

Biomedical HIV Prevention
consumption, contingent take-home incentive and non-contingent take-home in
methadone maintenance. Progress in Neuro-Psychopharmacology and Biological
Psychiatry 35, 2: 483-489.
Ghys, P.D., Diallo, M.O., Ettiègne-Traoré, V., Satten, G.A., Anoma, C.K., Maurice, C., Kadjo,
J.-C., Coulibaly, I.-M., Wiktor, S.Z., Greenberg, A.E. & Laga, M. (2001). Effect of
interventions to control sexually transmitted disease on the incidence of HIV
infection in female sex workers. AIDS 15, 11: 1421-1431.
Gilead (2008). Emtriva package insert.
Gilead (2010). Viread package insert.
Girard, M.P., Osmanov, S.K. & Kieny, M.P. (2006). A review of vaccine research and
development: The human immunodeficiency virus (HIV). Vaccine 24, 19: 4062-4081.
Grant, R.M., Lama, J.R., Anderson, P.L., McMahan, V., Liu, A.Y., Vargas, L., Goicochea, P.,
Casapía, M., Guanira-Carranza, J.V., Ramirez-Cardich, M.E., Montoya-Herrera, O.,
Fernández, T., Veloso, V.G., Buchbinder, S.P., Chariyalertsak, S., Schechter, M.,
Bekker, L.-G., Mayer, K.H., Kallás, E.G., Amico, K.R., Mulligan, K., Bushman, L.R.,
Hance, R.J., Ganoza, C., Defechereux, P., Postle, B., Wang, F., McConnell, J.J.,
Zheng, J.-H., Lee, J., Rooney, J.F., Jaffe, H.S., Martinez, A.I., Burns, D.N. & Glidden,
D.V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have
sex with men. New England Journal of Medicine 363, 27: 2587-2599.
Gray, G., Allen, M., Bekker, L., Churchyard, G., Mlisana, K., Nchabeleng, M., Moodie, F.,
Metch, B. & Cassis-Ghavami, F. (2008). Results from the Phambili (HVTN 503)
study: A multicenter double-blind placebo-controlled Phase IIB test-of-concept
study to evaluate the safety and efficacy of the MRKad5 HIV-1 gag/pol/nef
vaccine in HIV-1 uninfected South Africans. AIDS Vaccine, Cape Town, South
Africa, 13-16 Ocober 2008.
Gray, R., Kigozi, G., Serwadda, D., Makumbi, F., Watya, S., Nalugoda, F., Kiwanuka, N.,
Moulton, L., Chaudhary, M. & Chen, M. (2007). Male circumcision for HIV
prevention in men in Rakai, Uganda: A randomised trial. The Lancet 369, 9562: 657-
666.
Grosskurth, H., Gray, R., Hayes, R., Mabey, D. & Wawer, M. (2000). Control of sexually
transmitted diseases for HIV-1 prevention: Understanding the implications of the
Mwanza and Rakai trials. The Lancet 355, 9219: 1981-1987.
Grosskurth, H., Todd, J., Mwijarubi, E., Mayaud, P., Nicoll, A., ka-Gina, G., Newell, J.,
Mabey, D., Hayes, R., Mosha, F., Senkoro, K., Changalucha, J., Klokke, A. &
Mugeye, K. (1995). Impact of improved treatment of sexually transmitted diseases
on HIV infection in rural Tanzania: Randomised controlled trial. The Lancet 346,
8974: 530-536.
Gunderson, E.W. & Fiellin, D.A. (2008). Office-based maintenance treatment of opioid
dependence: How does it compare with traditional approaches? CNS Drugs 22: 99-
111.
Halperin, D. & Epstein, H. (2007). Why is HIV prevalence so severe in southern Africa? The
role of multiple concurrent partnerships and lack of male circumcision:
Implications for AIDS prevention. The Southern African Journal of HIV Medicine 8: 19-
25.
Hargreaves, J.R., Morison, L.A., Kim, J.C., Busza, J., Phetla, G., Porter, J.D., Watts, C. &
Pronyk, P.M. (2009). Characteristics of sexual partnerships, not just of individuals,
39